References
- Bishop JF, Matthews JP, McGrath K, Yuen K, Wolf MM, Szer J. Factors influencing 20-hour increments after platelet transfusion. Transfusion 1991; 31:392-6.
- Shibata Y, Juji T, Nishizawa Y, Sakamoto H, Ozawa N. Detection of platelet antibodies by a newly developed mixed agglutination with platelets. Vox Sang 1981;41:25-31.
- Terasaki PI,Bernoco D, Park MS, Ozturk G, Imaki Y. Microdroplet testing for HLA-A, -B, -C and -D antigens. Am J Clin Pathol 1978;69:103-7.
- Legler TJ, Fischer I, Dittman J,et al. Frequency and causes of refractoriness in multiply transfused patients. Ann Hematol 1997;74:185-9.
- Sanz C, Freire C, Alcorta I, Ordinas A, Pereira A. Platelet-specific antibodies in HLA-immunized patients receiving chronic platelet support. Transfusion 2001;41:762-5.
- McFarland JG, Larson EB, Hillman RS, Slichter SJ. Cost-benefit analysis of a plateletapheresis program.Transfusion 1986;26:91-7.
- The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med 1997;337:1861-9.
- Moroff G, Garratty G, Heal JM,et al. Selection of platelets for refractory patients by HLA matching and prospective crossmatching. Transfusion 1992; 32:633-40.
- Petz LD, Garratty G, Calhoun L, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion 2000;40:1446-56.